MS
Maree Therese Smith

Elite Scholar


371
Works
9,473
Citations
50
H-Index
Search Authors
Author Statistics

Maree Therese Smith

Also known as: M SMITH, M T Smith, M T. Smith, M. Smith, M. T. Smith

371

Total Works

9,473

Citations

50

H-Index

145

i10-Index

Citation & Works Trend by Year
47 years active
Top Research Topics
Pain Mechanisms and Treatments (184) Pain Management and Opioid Use (141) Neuropeptides and Animal Physiology (78) Pain Management and Treatment (51) Anesthesia and Pain Management (42)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy Inflammopharmacology 1
2026 Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants ACS Infectious Diseases 3
2026 Burrowing Behavior as a Pain-Behavioral Readout in Rodent Pain Models Neuromethods 0
2025 Role of complement components 3A (C3A) and 5A (C5A) in the acute-to-chronic pain transition in a mouse model of neuropathic pain Immunobiology 1
2025 Significant hindlimb static weight-bearing asymmetry persists for 40-weeks in a longitudinal study in two widely used rat models of surgically induced osteoarthritis knee pain Frontiers in Pharmacology 3
2025 Florasulam Is a Potent Inhibitor of Mycobacterium tuberculosis Acetohydroxyacid Synthase and Possesses In Vivo Antituberculosis Activity ACS Infectious Diseases 7
2025 The angiotensin II type 2 receptor antagonists, PD123,319 ((S-( +)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid), EMA300 (5-(2,2-diphenylacetyl)-4-[(4-methoxy-3-methylphenyl)methyl]-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-6-carboxylic acid) and EMA401 ((3S)-5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid), evoke pain relief in a varicella zoster virus-induced rat model of neuropathic pain Inflammopharmacology 1
2025 Evaluation of long-term outcomes with intrathecal opioid treatment: a comparison utilizing data derived from pain clinic populations in Australia and New Zealand Frontiers in Pain Research 0
2024 The role and treatment potential of the complement pathway in chronic pain Journal of Pain 14
2024 J-2156, a small molecule somatostatin type 4 receptor agonist, alleviated hindpaw hypersensitivity in the streptozotocin-induced rat model of painful diabetic neuropathy but with a 2-fold decrease in potency at an advanced stage in the model, mimicking morphine Frontiers in Pharmacology 5
2024 Side Effects of Central Analgesic Drugs Springer eBooks 0
2023 seco-1-Azacubane-2-carboxylic Acid: Derivative Scope and Comparative Biological Evaluation The Journal of Organic Chemistry 1
2023 Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation Current Opinion in Pharmacology 7
2023 In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes European Journal of Drug Metabolism and Pharmacokinetics 1
2023 The NLRP3 inflammasome: role in the pathobiology of chronic pain Inflammopharmacology 63

Data source: OpenAlex API